Chronic obstructive pulmonary disease in combination with cardiovascular diseases: treatment with inhalatory cholinolytic drugs1


如何引用文章

全文:

参考

  1. Reynolds R. J., Buford J. G., George R. B. Treating asthma and COPD in patients with heart disease. J. Respir. Dis. 1982; 3: 41.
  2. Behar S., Panosh A., Rekher-Reiss H. et al. Prevalence and prognosis of chronic obstructive pulmonary disease among 5,839 consecutive patients with acute myocardial infarction. SPRINT Study Group. Am. J. Med. 1992; 93: 637.
  3. Shih H. Т., Webb С. R., Conway W. A. et al. Frequency and significance of cardiac arrhythmias in chronic obstructive lung disease. Chest 1988; 94: 44.
  4. Jousilahti P., Vartiainen E., Tuomilehto J. et al. Symptoms of chronic bronchitis and the risk of coronary disease. Lancet 1996; 348: 567.
  5. Fuso L., Incalz R. A., Pistelli R. et al. Predicting mortality of patients hospitalized for acutely exacerbated chronic obstructive pulmonary disease. Am. J. Med. 1995; 98: 272.
  6. Козлова Л. И., Бузунов Р. В., Чучалин А. Г. Хроническая обструктивная болезнь легкого у больных с ишемической болезнью сердца: 15-летнее исследование. Тер. арх. 2001; 73 (3, прил. 10): 11-21.
  7. Summers R. J., Molnaar P., Russell F. et al. Coexistence and localization of beta 1- and beta 2-adrenoceptors in the human heart. Eur. Heart J. 1989; 10 (suppl. B): 11-21.
  8. Neville E., Corns P. A., Vivian J. et al. Nebulised salbutamol and angina. Br. Med. J. 1982; 285 (6344): 796-797.
  9. Au D. H., Curtis J. R., Every N. R. et al. Association between inhaled beta-agonists and the risk of unstable angina and myocardial infarction. Chest 2002: 12! (3): 846-851.
  10. Oga Т., Nishimura K., Tsukino M. et al. A comparison of the effects of salbutamol and ipratropium bromide on exercise endurance in patients with COPD. Chest 2003; 123 (6): 1810- 1816.
  11. Langley S. J., Towse L., Kesten S., Calverley P. M. Heart rate and rhythm analysis from holter monitoring in COPD patients receiving tiotropium. A. J. Respir. Crit. Care Med. 2002; 165 (8): A592.
  12. ZuWallack R., Morganroth J., Lanes S., Kesten S. Electrocardiographic evaluations in COPD patients treated with tiotropium in 1-year clinical trials. Am. J. Respir. Crit. Care Med. 2003; 167 (7): A94.
  13. O'Donnell D. E., Helgo Magnussen H., Gerken F. et al. Mechanisms of improved exercise tolerance in COPD in response to tiotropium. Eur. Respir. J. 2002; 19 (suppl.): P1826.
  14. O'Donnell D. E., Magnussen H., Gerken F. et al. Cardiovascular evaluation of tiotropium during constant work rate exercise in COPD. Eur. Respir. J. 2003; 22 (suppl. 45): 49s.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Consilium Medicum, 2004

Creative Commons License
此作品已接受知识共享署名-非商业性使用-相同方式共享 4.0国际许可协议的许可。
 

Address of the Editorial Office:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Correspondence address:

  • Alabyan Street, 13/1, Moscow, 127055, Russian Federation

Managing Editor:

  • Tel.: +7 (926) 905-41-26
  • E-mail: e.gorbacheva@ter-arkhiv.ru

 

 © 2018-2021 "Consilium Medicum" Publishing house